25 XP   0   0   10

Dimed S.A. Distribuidora de Medicamentos
Buy, Hold or Sell?

Let's analyse Dimed together

PenkeI guess you are interested in Dimed S.A. Distribuidora de Medicamentos. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dimed S.A. Distribuidora de Medicamentos. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dimed S.A. Distribuidora de Medicamentos

I send you an email if I find something interesting about Dimed S.A. Distribuidora de Medicamentos.

Quick analysis of Dimed (30 sec.)










What can you expect buying and holding a share of Dimed? (30 sec.)

How much money do you get?

How much money do you get?
R$0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
R$7.67
Expected worth in 1 year
R$8.17
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
R$0.70
Return On Investment
5.7%

For what price can you sell your share?

Current Price per Share
R$12.13
Expected price per share
R$10.94 - R$12.69
How sure are you?
50%

1. Valuation of Dimed (5 min.)




Live pricePrice per Share (EOD)

R$12.13

Intrinsic Value Per Share

R$-8.30 - R$7.19

Total Value Per Share

R$-0.63 - R$14.86

2. Growth of Dimed (5 min.)




Is Dimed growing?

Current yearPrevious yearGrowGrow %
How rich?$228.9m$215.2m$10.8m4.8%

How much money is Dimed making?

Current yearPrevious yearGrowGrow %
Making money$4.4m$4.2m$131.2k3.0%
Net Profit Margin2.0%2.3%--

How much money comes from the company's main activities?

3. Financial Health of Dimed (5 min.)




What can you expect buying and holding a share of Dimed? (5 min.)

Welcome investor! Dimed's management wants to use your money to grow the business. In return you get a share of Dimed.

What can you expect buying and holding a share of Dimed?

First you should know what it really means to hold a share of Dimed. And how you can make/lose money.

Speculation

The Price per Share of Dimed is R$12.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dimed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dimed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is R$7.67. Based on the TTM, the Book Value Change Per Share is R$0.12 per quarter. Based on the YOY, the Book Value Change Per Share is R$0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is R$0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dimed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 R$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per Share
Usd Eps0.030.3%0.030.2%0.030.2%0.030.2%0.020.2%
Usd Book Value Change Per Share0.020.1%0.020.2%0.030.2%0.050.4%0.030.2%
Usd Dividend Per Share0.010.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.030.2%0.040.3%0.040.3%0.060.5%0.040.3%
Usd Price Per Share2.35-2.23-2.46-24.04-46.96-
Price to Earnings Ratio18.37-18.80-21.99-240.34-607.45-
Price-to-Total Gains Ratio84.95-76.18--22.93-887.88-1,960.05-
Price to Book Ratio1.52-1.46-1.74-34.46-86.94-
Price-to-Total Gains Ratio84.95-76.18--22.93-887.88-1,960.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.43813
Number of shares410
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.05
Usd Total Gains Per Share0.040.06
Gains per Quarter (410 shares)14.3523.65
Gains per Year (410 shares)57.4094.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1174147187685
2338210437152180
35012316155229275
46616421874305370
58320427592381465
699245332110457560
7116286389129533655
8132327446147610750
9149368503166686845
10165409560184762940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%64.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%17.03.00.085.0%37.03.00.092.5%56.03.05.087.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%58.00.06.090.6%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%18.02.00.090.0%38.02.00.095.0%59.02.03.092.2%

Fundamentals of Dimed

About Dimed S.A. Distribuidora de Medicamentos

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermocosmetics in Brazil. The company operates in Retail and Wholesale segments. It offers its products through distribution centers in the states of Rio Grande do Sul, Paraná, and Espírito Santo. The company operates through its stores in Rio Grande do Sul, Santa Catarina, Paraná, and São Paulo. It offers its products under Panvel brand name. In addition, the company owns, leases, manages, and sells properties. Dimed S.A. Distribuidora de Medicamentos is headquartered in Eldorado do Sul, Brazil.

Fundamental data was last updated by Penke on 2024-03-12 10:01:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Dimed S.A. Distribuidora de Medicamentos.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dimed earns for each R$1 of revenue.

  • Above 10% is considered healthy but always compare Dimed to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 2.1% means that R$0.02 for each R$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 2.1%. The company is making a profit. +1
  • The TTM is 2.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.0%+0.1%
TTM2.0%YOY2.3%-0.2%
TTM2.0%5Y2.4%-0.4%
5Y2.4%10Y2.4%0.0%
1.1.2. Return on Assets

Shows how efficient Dimed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dimed to the Drug Manufacturers - General industry mean.
  • 0.8% Return on Assets means that Dimed generated R$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%+0.0%
TTM0.8%YOY0.9%-0.1%
TTM0.8%5Y1.0%-0.2%
5Y1.0%10Y1.4%-0.4%
1.1.3. Return on Equity

Shows how efficient Dimed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dimed to the Drug Manufacturers - General industry mean.
  • 2.1% Return on Equity means Dimed generated R$0.02 for each R$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.0%+0.1%
TTM2.0%YOY2.0%0.0%
TTM2.0%5Y2.5%-0.5%
5Y2.5%10Y3.1%-0.6%

1.2. Operating Efficiency of Dimed S.A. Distribuidora de Medicamentos.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dimed is operating .

  • Measures how much profit Dimed makes for each R$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dimed to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 4.9% means the company generated R$0.05  for each R$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 4.9%. The company is operating less efficient.
  • The TTM is 4.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.3%+0.6%
TTM4.3%YOY3.7%+0.6%
TTM4.3%5Y5.1%-0.8%
5Y5.1%10Y3.4%+1.7%
1.2.2. Operating Ratio

Measures how efficient Dimed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are R$0.96 for each R$1 in net sales.

Let's take a look of the Operating Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.962. The company is less efficient in keeping operating costs low.
  • The TTM is 0.964. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.962TTM0.964-0.001
TTM0.964YOY0.967-0.003
TTM0.9645Y1.303-0.340
5Y1.30310Y1.199+0.104

1.3. Liquidity of Dimed S.A. Distribuidora de Medicamentos.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dimed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.71 means the company has R$1.71 in assets for each R$1 in short-term debts.

Let's take a look of the Current Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 1.714. The company is able to pay all its short-term debts. +1
  • The TTM is 1.556. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.714TTM1.556+0.159
TTM1.556YOY1.746-0.190
TTM1.5565Y1.731-0.175
5Y1.73110Y1.205+0.526
1.3.2. Quick Ratio

Measures if Dimed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dimed to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 1.04 means the company can pay off R$1.04 for each R$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 1.041. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.725. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.041TTM0.725+0.315
TTM0.725YOY0.897-0.171
TTM0.7255Y0.841-0.115
5Y0.84110Y0.747+0.094

1.4. Solvency of Dimed S.A. Distribuidora de Medicamentos.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dimed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dimed to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.61 means that Dimed assets are financed with 61.3% credit (debt) and the remaining percentage (100% - 61.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 0.613. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.601. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.601+0.012
TTM0.601YOY0.569+0.032
TTM0.6015Y0.586+0.014
5Y0.58610Y0.556+0.030
1.4.2. Debt to Equity Ratio

Measures if Dimed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dimed to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 158.6% means that company has R$1.59 debt for each R$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The MRQ is 1.586. The company is just able to pay all its debts with equity.
  • The TTM is 1.506. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.586TTM1.506+0.080
TTM1.506YOY1.326+0.180
TTM1.5065Y1.445+0.062
5Y1.44510Y1.279+0.165

2. Market Valuation of Dimed S.A. Distribuidora de Medicamentos

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every R$1 in earnings Dimed generates.

  • Above 15 is considered overpriced but always compare Dimed to the Drug Manufacturers - General industry mean.
  • A PE ratio of 18.37 means the investor is paying R$18.37 for every R$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The EOD is 19.041. Based on the earnings, the company is fair priced.
  • The MRQ is 18.366. Based on the earnings, the company is fair priced.
  • The TTM is 18.805. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD19.041MRQ18.366+0.675
MRQ18.366TTM18.805-0.439
TTM18.805YOY21.994-3.189
TTM18.8055Y240.341-221.536
5Y240.34110Y607.447-367.106
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The EOD is 10.819. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.435. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 2.882. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.819MRQ10.435+0.384
MRQ10.435TTM2.882+7.553
TTM2.882YOY-0.184+3.066
TTM2.8825Y-6.926+9.808
5Y-6.92610Y966.032-972.958
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dimed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.52 means the investor is paying R$1.52 for each R$1 in book value.

Let's take a look of the Price to Book Ratio trends of Dimed S.A. Distribuidora de Medicamentos:

  • The EOD is 1.581. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.525. Based on the equity, the company is underpriced. +1
  • The TTM is 1.461. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.581MRQ1.525+0.056
MRQ1.525TTM1.461+0.064
TTM1.461YOY1.735-0.274
TTM1.4615Y34.463-33.002
5Y34.46310Y86.937-52.473
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dimed S.A. Distribuidora de Medicamentos compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0890.124-28%0.150-41%0.231-62%0.146-39%
Book Value Per Share--7.6727.572+1%7.075+8%5.792+32%4.116+86%
Current Ratio--1.7141.556+10%1.746-2%1.731-1%1.205+42%
Debt To Asset Ratio--0.6130.601+2%0.569+8%0.586+5%0.556+10%
Debt To Equity Ratio--1.5861.506+5%1.326+20%1.445+10%1.279+24%
Dividend Per Share--0.0490.050-3%0.048+1%0.056-13%0.057-15%
Eps--0.1590.148+8%0.141+13%0.130+23%0.110+44%
Free Cash Flow Per Share--0.2800.243+16%0.021+1213%0.066+322%0.056+400%
Free Cash Flow To Equity Per Share--0.4110.124+232%-0.108+126%0.275+50%0.176+134%
Gross Profit Margin---10.410-6.243-40%-6.225-40%-3.029-71%-1.015-90%
Intrinsic Value_10Y_max--7.190--------
Intrinsic Value_10Y_min---8.303--------
Intrinsic Value_1Y_max--0.296--------
Intrinsic Value_1Y_min--0.041--------
Intrinsic Value_3Y_max--1.214--------
Intrinsic Value_3Y_min---0.632--------
Intrinsic Value_5Y_max--2.521--------
Intrinsic Value_5Y_min---2.128--------
Market Cap1800880352.960+4%1737040406.4001644468994.875+6%1855189036.360-6%17779150424.109-90%34699768676.279-95%
Net Profit Margin--0.0210.020+3%0.023-7%0.024-12%0.024-13%
Operating Margin--0.0490.043+15%0.037+32%0.051-4%0.034+45%
Operating Ratio--0.9620.9640%0.9670%1.303-26%1.199-20%
Pb Ratio1.581+4%1.5251.461+4%1.735-12%34.463-96%86.937-98%
Pe Ratio19.041+4%18.36618.805-2%21.994-16%240.341-92%607.447-97%
Price Per Share12.130+4%11.70011.070+6%12.235-4%119.614-90%233.654-95%
Price To Free Cash Flow Ratio10.819+4%10.4352.882+262%-0.184+102%-6.926+166%966.032-99%
Price To Total Gains Ratio88.071+4%84.94976.178+12%-22.931+127%887.878-90%1960.050-96%
Quick Ratio--1.0410.725+43%0.897+16%0.841+24%0.747+39%
Return On Assets--0.0080.008+3%0.009-7%0.010-21%0.014-42%
Return On Equity--0.0210.020+6%0.020+3%0.025-16%0.031-33%
Total Gains Per Share--0.1380.174-21%0.198-31%0.287-52%0.204-32%
Usd Book Value--228950457.000226119522.750+1%215257935.000+6%174647482.950+31%123738645.150+85%
Usd Book Value Change Per Share--0.0180.025-28%0.030-41%0.046-62%0.029-39%
Usd Book Value Per Share--1.5421.522+1%1.422+8%1.164+32%0.827+86%
Usd Dividend Per Share--0.0100.010-3%0.010+1%0.011-13%0.011-15%
Usd Eps--0.0320.030+8%0.028+13%0.026+23%0.022+44%
Usd Free Cash Flow--8364615.0007239919.500+16%883797.000+846%2074088.850+303%1635727.950+411%
Usd Free Cash Flow Per Share--0.0560.049+16%0.004+1213%0.013+322%0.011+400%
Usd Free Cash Flow To Equity Per Share--0.0830.025+232%-0.022+126%0.055+50%0.035+134%
Usd Market Cap361976950.945+4%349145121.686330538267.970+6%372892996.308-6%3573609235.246-90%6974653503.932-95%
Usd Price Per Share2.438+4%2.3522.225+6%2.459-4%24.042-90%46.964-95%
Usd Profit--4752645.0004423105.500+7%4291902.750+11%3903399.900+22%3309138.375+44%
Usd Revenue--227159949.000217308135.000+5%190884675.000+19%166351378.800+37%138377661.075+64%
Usd Total Gains Per Share--0.0280.035-21%0.040-31%0.058-52%0.041-32%
 EOD+4 -4MRQTTM+24 -12YOY+22 -145Y+17 -1910Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of Dimed S.A. Distribuidora de Medicamentos based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.041
Price to Book Ratio (EOD)Between0-11.581
Net Profit Margin (MRQ)Greater than00.021
Operating Margin (MRQ)Greater than00.049
Quick Ratio (MRQ)Greater than11.041
Current Ratio (MRQ)Greater than11.714
Debt to Asset Ratio (MRQ)Less than10.613
Debt to Equity Ratio (MRQ)Less than11.586
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.008
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Dimed S.A. Distribuidora de Medicamentos based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.226
Ma 20Greater thanMa 5012.037
Ma 50Greater thanMa 10011.938
Ma 100Greater thanMa 20012.106
OpenGreater thanClose11.880
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in BRL. All numbers in thousands.

Summary
Total Assets2,945,705
Total Liabilities1,806,648
Total Stockholder Equity1,139,057
 As reported
Total Liabilities 1,806,648
Total Stockholder Equity+ 1,139,057
Total Assets = 2,945,705

Assets

Total Assets2,945,705
Total Current Assets1,735,157
Long-term Assets1,210,548
Total Current Assets
Cash And Cash Equivalents 15,578
Short-term Investments 249,453
Net Receivables 539,015
Inventory 931,111
Total Current Assets  (as reported)1,735,157
Total Current Assets  (calculated)1,735,157
+/-0
Long-term Assets
Property Plant Equipment 1,062,027
Goodwill 6,783
Intangible Assets 74,105
Other Assets 56,231
Long-term Assets  (as reported)1,210,548
Long-term Assets  (calculated)1,199,146
+/- 11,402

Liabilities & Shareholders' Equity

Total Current Liabilities1,012,058
Long-term Liabilities794,590
Total Stockholder Equity1,139,057
Total Current Liabilities
Short-term Debt 289,869
Short Long Term Debt 128,915
Accounts payable 512,595
Other Current Liabilities 73,196
Total Current Liabilities  (as reported)1,012,058
Total Current Liabilities  (calculated)1,004,575
+/- 7,483
Long-term Liabilities
Long term Debt Total 784,796
Long-term Liabilities  (as reported)794,590
Long-term Liabilities  (calculated)784,796
+/- 9,794
Total Stockholder Equity
Common Stock955,668
Retained Earnings 43,991
Accumulated Other Comprehensive Income 170,043
Other Stockholders Equity -30,645
Total Stockholder Equity (as reported)1,139,057
Total Stockholder Equity (calculated)1,139,057
+/-0
Other
Capital Stock955,668
Cash And Equivalents9,674
Cash and Short Term Investments 265,031
Common Stock Shares Outstanding 147,781
Current Deferred Revenue136,398
Liabilities and Stockholders Equity 2,945,705
Net Debt 1,059,087
Net Invested Capital 1,577,972
Net Working Capital 723,099
Property Plant and Equipment Gross 1,804,419
Short Long Term Debt Total 1,074,665



Balance Sheet

Currency in BRL. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-03-312008-12-312007-12-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-03-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
147,793
156,506
145,207
172,018
180,584
0
217,513
217,513
0
199,616
234,294
234,294
253,461
275,749
0
333,081
311,863
315,475
347,161
377,105
360,463
378,554
393,614
442,155
434,869
437,263
457,018
500,816
512,711
527,245
579,734
599,894
574,097
636,431
669,903
719,271
677,438
704,124
709,386
759,967
741,417
779,003
756,970
820,973
775,896
820,240
829,558
950,172
885,296
921,353
954,818
1,000,375
1,206,297
1,285,724
1,352,517
1,460,285
1,588,261
1,537,852
2,176,369
2,194,373
2,253,459
2,141,926
2,253,832
2,381,060
2,482,438
2,504,634
2,569,515
2,733,126
2,816,567
2,783,735
2,945,705
2,945,7052,783,7352,816,5672,733,1262,569,5152,504,6342,482,4382,381,0602,253,8322,141,9262,253,4592,194,3732,176,3691,537,8521,588,2611,460,2851,352,5171,285,7241,206,2971,000,375954,818921,353885,296950,172829,558820,240775,896820,973756,970779,003741,417759,967709,386704,124677,438719,271669,903636,431574,097599,894579,734527,245512,711500,816457,018437,263434,869442,155393,614378,554360,463377,105347,161315,475311,863333,0810275,749253,461234,294234,294199,6160217,513217,5130180,584172,018145,207156,506147,793
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
590,440
540,856
582,495
586,174
705,024
633,663
659,507
685,382
727,126
702,804
770,640
813,547
851,138
963,573
858,033
1,436,985
1,376,502
1,436,131
1,247,790
1,314,467
1,395,084
1,436,783
1,411,566
1,432,112
1,558,547
1,622,645
1,585,439
1,735,157
1,735,1571,585,4391,622,6451,558,5471,432,1121,411,5661,436,7831,395,0841,314,4671,247,7901,436,1311,376,5021,436,985858,033963,573851,138813,547770,640702,804727,126685,382659,507633,663705,024586,174582,495540,856590,4400000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,340
17,772
5,292
9,781
58,792
11,742
14,781
10,697
39,141
12,225
56,607
2,525
71,437
3,616
4,389
3,585
5,511
27,253
47,351
18,672
54,435
43,319
41,561
22,862
25,715
-664,461
12,272
15,578
15,57812,272-664,46125,71522,86241,56143,31954,43518,67247,35127,2535,5113,5854,3893,61671,4372,52556,60712,22539,14110,69714,78111,74258,7929,7815,29217,77222,3400000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65,457
305,701
250,877
124,809
186,855
155,216
52,614
85,409
141,388
131,640
243,280
180,937
249,453
249,453180,937243,280131,640141,38885,40952,614155,216186,855124,809250,877305,70165,4570000000000000000000000000000000000000000000000000000000000
       Net Receivables 
39,011
37,900
42,633
47,910
55,062
0
78,434
78,434
0
74,398
77,817
77,817
81,376
85,726
0
89,682
92,608
111,419
110,865
116,059
112,071
129,710
127,716
132,816
139,722
151,749
163,105
162,409
173,204
158,719
182,566
153,846
130,442
174,671
175,624
210,162
189,972
193,600
198,219
215,042
200,239
231,148
206,402
210,872
181,120
213,815
206,550
247,365
232,040
243,439
265,152
263,011
86,657
232,726
245,390
350,481
246,485
250,995
258,189
285,753
292,119
394,721
412,164
446,397
487,203
475,177
471,130
504,657
490,515
484,878
539,015
539,015484,878490,515504,657471,130475,177487,203446,397412,164394,721292,119285,753258,189250,995246,485350,481245,390232,72686,657263,011265,152243,439232,040247,365206,550213,815181,120210,872206,402231,148200,239215,042198,219193,600189,972210,162175,624174,671130,442153,846182,566158,719173,204162,409163,105151,749139,722132,816127,716129,710112,071116,059110,865111,41992,60889,682085,72681,37677,81777,81774,398078,43478,434055,06247,91042,63337,90039,011
       Other Current Assets 
2,413
2,682
2,032
2,345
2,057
0
3,652
3,652
0
3,709
3,125
3,125
4,698
6,663
0
6,219
8,831
715
9,089
191
0
0
191
191
191
191
191
191
191
191
191
0
2,832
2,396
2,031
1,844
191
191
191
0
191
191
191
191
191
191
191
191
191
191
191
518
951
191
308
191
208
6,087
9,764
208
208
394,721
412,164
446,397
487,203
475,177
471,130
0
678,828
0
0
00678,8280471,130475,177487,203446,397412,164394,7212082089,7646,08720819130819195151819119119119119119119119119119119101911911911,8442,0312,3962,8320191191191191191191191191191001919,0897158,8316,21906,6634,6983,1253,1253,70903,6523,65202,0572,3452,0322,6822,413
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
503,493
515,084
538,970
609,147
624,688
679,819
739,384
817,871
817,328
894,136
939,365
985,976
1,045,655
1,093,068
1,137,403
1,174,579
1,193,922
1,198,296
1,210,548
1,210,5481,198,2961,193,9221,174,5791,137,4031,093,0681,045,655985,976939,365894,136817,328817,871739,384679,819624,688609,147538,970515,084503,4930000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
21,315
21,318
21,322
20,745
19,724
0
20,018
20,018
0
17,994
19,740
19,740
14,280
24,052
0
28,697
37,543
40,646
42,103
46,343
41,261
43,496
46,599
62,689
56,563
66,332
68,539
80,368
78,587
93,605
116,898
154,973
156,278
160,321
166,097
186,755
188,474
189,780
191,319
193,907
193,870
190,368
195,413
200,908
202,118
204,042
207,593
208,367
215,157
224,434
229,105
234,418
461,548
469,981
487,384
551,658
563,612
615,156
660,690
723,688
722,310
877,839
827,356
874,106
930,475
968,684
1,007,428
1,034,437
1,053,584
1,058,945
1,062,027
1,062,0271,058,9451,053,5841,034,4371,007,428968,684930,475874,106827,356877,839722,310723,688660,690615,156563,612551,658487,384469,981461,548234,418229,105224,434215,157208,367207,593204,042202,118200,908195,413190,368193,870193,907191,319189,780188,474186,755166,097160,321156,278154,973116,89893,60578,58780,36868,53966,33256,56362,68946,59943,49641,26146,34342,10340,64637,54328,697024,05214,28019,74019,74017,994020,01820,018019,72420,74521,32221,31821,315
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,541
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,921
7,836
7,781
7,559
7,270
7,196
7,553
7,167
6,841
7,144
6,789
6,783
6,7836,7897,1446,8417,1677,5537,1967,2707,5597,7817,8367,92100000000000000000000000000000000000000004,541000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
284
284
284
284
284
284
279
284
284
284
284
284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002842842842842842792842842842842842840000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
1,411
4,083
0
4,710
4,439
4,639
4,623
4,807
11,178
11,610
12,814
6,799
14,210
6,463
6,615
6,771
17,695
17,912
19,075
9,114
19,822
20,540
20,137
8,691
10,246
10,174
10,303
11,386
11,666
12,319
13,704
14,799
17,091
18,123
19,541
20,699
20,993
21,916
23,121
24,979
25,800
27,765
31,010
33,085
36,806
37,712
39,905
45,868
48,582
44,116
48,000
52,674
55,445
59,754
65,067
69,895
71,084
72,053
74,105
74,10572,05371,08469,89565,06759,75455,44552,67448,00044,11648,58245,86839,90537,71236,80633,08531,01027,76525,80024,97923,12121,91620,99320,69919,54118,12317,09114,79913,70412,31911,66611,38610,30310,17410,2468,69120,13720,54019,8229,11419,07517,91217,6956,7716,6156,46314,2106,79912,81411,61011,1784,8074,6234,6394,4394,71004,0831,411000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
209
707
-238,574
1,075
1,029
983
937
891
414
58,077
210,630
170,291
67,483
100,513
156,577
146,444
258,245
195,642
269,647
269,647195,642258,245146,444156,577100,51367,483170,291210,63058,0774148919379831,0291,075-238,5747072090000000000000000000000000000000000000000000000000000
> Total Liabilities 
65,848
70,895
56,772
78,396
80,388
0
109,322
109,322
0
85,264
116,551
116,551
128,074
144,942
0
182,481
154,962
151,458
176,370
204,071
179,348
190,187
198,048
242,912
225,841
217,821
228,316
267,176
270,169
271,434
310,011
322,997
290,153
337,328
365,205
407,969
360,597
375,820
374,394
415,825
387,057
415,259
384,928
439,323
380,492
414,037
415,443
523,425
447,409
479,731
502,068
536,463
729,006
803,903
853,939
936,109
1,053,969
1,008,217
1,172,741
1,183,733
1,237,295
1,117,181
1,224,486
1,334,865
1,415,469
1,425,056
1,478,517
1,624,964
1,689,741
1,657,889
1,806,648
1,806,6481,657,8891,689,7411,624,9641,478,5171,425,0561,415,4691,334,8651,224,4861,117,1811,237,2951,183,7331,172,7411,008,2171,053,969936,109853,939803,903729,006536,463502,068479,731447,409523,425415,443414,037380,492439,323384,928415,259387,057415,825374,394375,820360,597407,969365,205337,328290,153322,997310,011271,434270,169267,176228,316217,821225,841242,912198,048190,187179,348204,071176,370151,458154,962182,4810144,942128,074116,551116,55185,2640109,322109,322080,38878,39656,77270,89565,848
   > Total Current Liabilities 
61,538
67,095
53,967
75,656
78,133
0
98,893
98,893
0
76,880
105,657
105,657
118,002
125,704
0
157,537
130,937
126,714
152,099
179,009
154,194
166,041
173,923
214,172
197,372
183,063
192,332
228,717
221,328
213,458
236,190
250,946
217,386
265,318
296,774
288,565
246,995
267,229
269,560
315,609
292,684
325,485
313,829
370,484
322,348
357,843
369,590
403,768
328,738
383,504
406,217
470,228
495,334
436,204
471,614
501,244
608,726
543,426
677,796
677,724
741,930
596,315
686,724
814,974
869,055
763,016
809,521
1,008,234
1,066,097
1,100,572
1,012,058
1,012,0581,100,5721,066,0971,008,234809,521763,016869,055814,974686,724596,315741,930677,724677,796543,426608,726501,244471,614436,204495,334470,228406,217383,504328,738403,768369,590357,843322,348370,484313,829325,485292,684315,609269,560267,229246,995288,565296,774265,318217,386250,946236,190213,458221,328228,717192,332183,063197,372214,172173,923166,041154,194179,009152,099126,714130,937157,5370125,704118,002105,657105,65776,880098,89398,893078,13375,65653,96767,09561,538
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,829
91,003
104,578
55,351
46,085
32,486
58,433
60,790
78,082
145,003
22,001
20,979
1,278
100,089
108,030
111,274
0
0
173,856
181,979
189,137
200,497
234,479
246,320
270,488
459,713
452,269
289,869
289,869452,269459,713270,488246,320234,479200,497189,137181,979173,85600111,274108,030100,0891,27820,97922,001145,00378,08260,79058,43332,48646,08555,351104,57891,00388,8290000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,829
91,003
104,578
55,351
46,085
32,486
58,433
60,790
78,082
145,003
22,001
25,770
1,278
103,411
135,214
139,497
53,400
54,377
53,740
55,867
54,532
58,071
88,331
97,870
118,395
302,337
293,671
128,915
128,915293,671302,337118,39597,87088,33158,07154,53255,86753,74054,37753,400139,497135,214103,4111,27825,77022,001145,00378,08260,79058,43332,48646,08555,351104,57891,00388,8290000000000000000000000000000000000000000000
       Accounts payable 
47,672
53,542
40,465
59,641
60,707
0
79,584
79,584
0
56,458
84,021
78,332
87,156
83,231
0
108,290
90,882
78,039
98,331
129,123
105,846
107,697
107,200
151,758
139,732
112,863
111,826
151,475
146,809
134,296
136,844
160,036
116,091
125,684
150,382
184,292
132,734
152,414
145,504
209,763
183,593
190,720
174,200
250,242
189,435
198,386
204,715
262,539
207,416
223,947
228,232
279,772
246,210
243,984
255,117
303,155
321,928
187,828
300,155
371,763
412,075
260,747
335,031
464,714
503,177
348,952
373,646
555,452
456,113
466,801
512,595
512,595466,801456,113555,452373,646348,952503,177464,714335,031260,747412,075371,763300,155187,828321,928303,155255,117243,984246,210279,772228,232223,947207,416262,539204,715198,386189,435250,242174,200190,720183,593209,763145,504152,414132,734184,292150,382125,684116,091160,036136,844134,296146,809151,475111,826112,863139,732151,758107,200107,697105,846129,12398,33178,03990,882108,290083,23187,15678,33284,02156,458079,58479,584060,70759,64140,46553,54247,672
       Other Current Liabilities 
12,833
12,895
12,635
14,428
16,075
0
19,218
19,218
0
19,792
21,444
27,133
30,187
39,956
0
46,647
36,873
45,872
50,501
46,634
44,858
54,778
63,088
58,712
54,250
66,432
76,286
72,341
69,503
73,937
93,842
85,520
81,411
84,377
87,086
83,038
83,290
82,435
94,855
84,908
80,086
93,934
102,513
90,747
91,186
102,812
109,299
95,084
88,782
43,679
51,040
50,289
42,736
28,980
34,557
47,002
35,894
46,155
59,664
73,130
63,426
161,712
134,076
130,322
165,381
179,585
189,555
182,294
150,271
60,982
73,196
73,19660,982150,271182,294189,555179,585165,381130,322134,076161,71263,42673,13059,66446,15535,89447,00234,55728,98042,73650,28951,04043,67988,78295,084109,299102,81291,18690,747102,51393,93480,08684,90894,85582,43583,29083,03887,08684,37781,41185,52093,84273,93769,50372,34176,28666,43254,25058,71263,08854,77844,85846,63450,50145,87236,87346,647039,95630,18727,13321,44419,792019,21819,218016,07514,42812,63512,89512,833
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
233,672
367,699
382,325
434,865
445,243
464,791
494,945
506,009
495,365
520,866
537,762
519,891
546,414
662,040
668,996
616,730
623,644
557,317
794,590
794,590557,317623,644616,730668,996662,040546,414519,891537,762520,866495,365506,009494,945464,791445,243434,865382,325367,699233,6720000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
375,475
427,152
436,748
453,901
482,248
491,590
474,588
495,973
508,061
501,790
522,883
637,746
652,696
601,052
609,147
546,911
784,796
784,796546,911609,147601,052652,696637,746522,883501,790508,061495,973474,588491,590482,248453,901436,748427,152375,475000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-88,829
-91,003
-104,578
-55,351
-46,085
-32,486
-58,433
-60,790
-78,082
27,034
220,781
238,326
317,847
232,060
278,461
311,754
467,449
452,960
336,519
346,480
367,972
385,526
376,558
381,969
366,228
190,381
193,240
345,881
345,881193,240190,381366,228381,969376,558385,526367,972346,480336,519452,960467,449311,754278,461232,060317,847238,326220,78127,034-78,082-60,790-58,433-32,486-46,085-55,351-104,578-91,003-88,8290000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
0
0
0
0
0
0
0
0
0
0
6,579
6,793
6,793
6,665
6,820
6,944
7,087
7,0876,9446,8206,6656,7936,7936,57900000000005400000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
81,945
85,611
88,435
93,622
100,196
100,196
108,191
108,191
108,191
114,352
117,743
117,743
125,387
130,807
130,807
150,600
156,901
164,017
170,791
173,034
181,115
188,367
195,566
199,243
209,028
219,442
228,702
233,640
242,542
255,811
269,723
276,897
283,944
299,103
304,698
311,302
316,841
328,304
334,992
344,142
354,360
363,744
372,042
381,650
395,404
406,203
414,115
426,747
437,887
441,622
452,750
463,912
477,291
481,821
498,578
524,176
534,292
529,635
1,003,628
1,010,640
1,016,164
1,024,745
1,029,346
1,046,195
1,046,361
1,079,578
1,090,998
1,108,162
1,126,826
1,125,846
1,139,057
1,139,0571,125,8461,126,8261,108,1621,090,9981,079,5781,046,3611,046,1951,029,3461,024,7451,016,1641,010,6401,003,628529,635534,292524,176498,578481,821477,291463,912452,750441,622437,887426,747414,115406,203395,404381,650372,042363,744354,360344,142334,992328,304316,841311,302304,698299,103283,944276,897269,723255,811242,542233,640228,702219,442209,028199,243195,566188,367181,115173,034170,791164,017156,901150,600130,807130,807125,387117,743117,743114,352108,191108,191108,191100,196100,19693,62288,43585,61181,945
   Common Stock
78,000
80,000
84,000
87,000
92,000
0
98,500
98,500
0
106,500
106,500
106,500
116,000
124,000
0
129,500
129,500
148,000
148,000
148,000
148,000
170,000
170,000
170,000
170,000
195,000
195,000
195,000
195,000
227,000
227,000
227,000
227,000
260,000
260,000
260,000
260,000
295,000
295,000
295,000
295,000
325,000
325,000
325,000
325,000
360,000
360,000
360,000
360,000
385,000
385,000
385,000
385,000
410,000
410,000
410,000
410,000
410,000
897,839
897,552
897,552
903,552
903,552
903,552
903,552
928,552
928,552
928,552
928,552
955,668
955,668
955,668955,668928,552928,552928,552928,552903,552903,552903,552903,552897,552897,552897,839410,000410,000410,000410,000410,000385,000385,000385,000385,000360,000360,000360,000360,000325,000325,000325,000325,000295,000295,000295,000295,000260,000260,000260,000260,000227,000227,000227,000227,000195,000195,000195,000195,000170,000170,000170,000170,000148,000148,000148,000148,000129,500129,5000124,000116,000106,500106,500106,500098,50098,500092,00087,00084,00080,00078,000
   Retained Earnings 
573
4,319
633
673
1,126
0
1,277
1,277
0
7,116
1,469
1,469
1,275
1,216
0
22,251
28,785
16,421
23,327
25,720
33,801
18,117
25,770
29,877
39,851
24,671
33,946
38,916
47,818
28,811
42,903
50,514
57,794
39,720
45,581
52,380
57,919
34,382
41,318
50,468
60,686
38,877
47,175
56,783
70,477
46,317
54,662
67,363
80,013
62,626
70,811
88,320
13,379
21,888
88,578
114,176
124,292
119,635
105,789
113,088
118,612
40,576
50,284
176,052
196,660
43,970
54,214
17,971
18,216
32,246
43,991
43,99132,24618,21617,97154,21443,970196,660176,05250,28440,576118,612113,088105,789119,635124,292114,17688,57821,88813,37988,32070,81162,62680,01367,36354,66246,31770,47756,78347,17538,87760,68650,46841,31834,38257,91952,38045,58139,72057,79450,51442,90328,81147,81838,91633,94624,67139,85129,87725,77018,11733,80125,72023,32716,42128,78522,25101,2161,2751,4691,4697,11601,2771,27701,1266736334,319573
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000-33,4090-28,5640000000000-3,061-6,004-2,126-616-547-114-73-133-133-133-1,326-1,326-1,326-1,078-1,078-1,078-883-617-850-617-1800-276-276-244-229-823-634-480-26-962-962-776-682-1,700-1,5040-234-1,779-400-400-1230-671-6710-872-659-2140-45
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-21,556
-14,448
-14,448
80,617
75,510
142,643
142,809
107,056
108,232
-29,368
-29,165
-30,640
-30,645
-30,645-30,640-29,165-29,368108,232107,056142,809142,64375,51080,617-14,448-14,448-21,5560000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in BRL. All numbers in thousands.




Cash Flow

Currency in BRL. All numbers in thousands.




Income Statement

Currency in BRL. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,324,540
Cost of Revenue-2,987,653
Gross Profit1,336,8871,336,887
 
Operating Income (+$)
Gross Profit1,336,887
Operating Expense-4,167,259
Operating Income157,281-2,830,372
 
Operating Expense (+$)
Research Development-
Selling General Administrative229,970
Selling And Marketing Expenses-
Operating Expense4,167,259229,970
 
Net Interest Income (+$)
Interest Income3,232
Interest Expense-96,424
Other Finance Cost-6,552
Net Interest Income-99,744
 
Pretax Income (+$)
Operating Income157,281
Net Interest Income-99,744
Other Non-Operating Income Expenses-
Income Before Tax (EBT)84,120157,281
EBIT - interestExpense = -96,424
88,022
184,446
Interest Expense96,424
Earnings Before Interest and Taxes (EBIT)-180,544
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax84,120
Tax Provision--3,902
Net Income From Continuing Ops88,02288,022
Net Income88,022
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-99,744
 

Technical Analysis of Dimed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dimed. The general trend of Dimed is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dimed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dimed S.A. Distribuidora de Medicamentos.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.57 < 12.60 < 12.69.

The bearish price targets are: 11.69 > 11.55 > 10.94.

Tweet this
Dimed S.A. Distribuidora de Medicamentos Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dimed S.A. Distribuidora de Medicamentos. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dimed S.A. Distribuidora de Medicamentos Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dimed S.A. Distribuidora de Medicamentos. The current macd is 0.07236668.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dimed price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dimed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dimed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Dimed S.A. Distribuidora de Medicamentos Daily Moving Average Convergence/Divergence (MACD) ChartDimed S.A. Distribuidora de Medicamentos Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dimed S.A. Distribuidora de Medicamentos. The current adx is 20.57.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Dimed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dimed S.A. Distribuidora de Medicamentos Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dimed S.A. Distribuidora de Medicamentos. The current sar is 12.56.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dimed S.A. Distribuidora de Medicamentos Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dimed S.A. Distribuidora de Medicamentos. The current rsi is 52.23. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Dimed S.A. Distribuidora de Medicamentos Daily Relative Strength Index (RSI) ChartDimed S.A. Distribuidora de Medicamentos Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dimed S.A. Distribuidora de Medicamentos. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 3/(-6 +6).

  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dimed price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dimed S.A. Distribuidora de Medicamentos Daily Stochastic Oscillator ChartDimed S.A. Distribuidora de Medicamentos Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dimed S.A. Distribuidora de Medicamentos. The current cci is 6.93436542.

Dimed S.A. Distribuidora de Medicamentos Daily Commodity Channel Index (CCI) ChartDimed S.A. Distribuidora de Medicamentos Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dimed S.A. Distribuidora de Medicamentos. The current cmo is 3.95606525.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Dimed S.A. Distribuidora de Medicamentos Daily Chande Momentum Oscillator (CMO) ChartDimed S.A. Distribuidora de Medicamentos Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dimed S.A. Distribuidora de Medicamentos. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dimed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dimed S.A. Distribuidora de Medicamentos Daily Williams %R ChartDimed S.A. Distribuidora de Medicamentos Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dimed S.A. Distribuidora de Medicamentos.

Dimed S.A. Distribuidora de Medicamentos Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dimed S.A. Distribuidora de Medicamentos. The current atr is 0.29465623.

Dimed S.A. Distribuidora de Medicamentos Daily Average True Range (ATR) ChartDimed S.A. Distribuidora de Medicamentos Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dimed S.A. Distribuidora de Medicamentos. The current obv is -868,800.

Dimed S.A. Distribuidora de Medicamentos Daily On-Balance Volume (OBV) ChartDimed S.A. Distribuidora de Medicamentos Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dimed S.A. Distribuidora de Medicamentos. The current mfi is 60.96.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Dimed S.A. Distribuidora de Medicamentos Daily Money Flow Index (MFI) ChartDimed S.A. Distribuidora de Medicamentos Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dimed S.A. Distribuidora de Medicamentos.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Dimed S.A. Distribuidora de Medicamentos Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dimed S.A. Distribuidora de Medicamentos based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.226
Ma 20Greater thanMa 5012.037
Ma 50Greater thanMa 10011.938
Ma 100Greater thanMa 20012.106
OpenGreater thanClose11.880
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dimed with someone you think should read this too:
  • Are you bullish or bearish on Dimed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dimed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dimed S.A. Distribuidora de Medicamentos

I send you an email if I find something interesting about Dimed S.A. Distribuidora de Medicamentos.


Comments

How you think about this?

Leave a comment

Stay informed about Dimed S.A. Distribuidora de Medicamentos.

Receive notifications about Dimed S.A. Distribuidora de Medicamentos in your mailbox!